Journal
CLINICAL BREAST CANCER
Volume 16, Issue 5, Pages 335-343Publisher
CIG MEDIA GROUP, LP
DOI: 10.1016/j.clbc.2016.05.012
Keywords
Clinical trials; Endocrine therapy; Pathways; Treatment strategies; Triple-negative breast cancer
Categories
Funding
- Cure Foundation [KG100492]
Ask authors/readers for more resources
Breast cancer is the second leading cause of cancer death in women, affecting 1.7 million patients every year worldwide. As a result of its heterogeneous nature, the genetic profile and associated clinical feature varies greatly among different breast cancer subtypes. With the advancement of molecular biology, our understanding of breast cancer has improved greatly in recent years. In this review, we examine different types of breast cancer and summarize their clinical features, current treatment schemes, and potential drug resistance profiles in response to treatments. We believe that the understanding of the molecular mechanisms of each treatment and subsequent drug resistance development will eventually lead to the discovery of more effective and efficient second-line therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available